OptimizeRx CorpOPRXEarnings & Financial Report
Nasdaq
OPRX Q3 2025 Key Financial Metrics
Revenue
$26.1M
Gross Profit
$17.5M
Operating Profit
$2.0M
Net Profit
$779.0K
Gross Margin
67.2%
Operating Margin
7.9%
Net Margin
3.0%
YoY Growth
22.3%
EPS
$0.04
Financial Flow
OptimizeRx Corp Q3 2025 Financial Summary
OptimizeRx Corp reported revenue of $26.1M for Q3 2025, with a net profit of $779.0K (3.0% margin). Cost of goods sold was $8.6M, operating expenses totaled $15.5M.
Key Financial Metrics
| Total Revenue | $26.1M |
|---|---|
| Net Profit | $779.0K |
| Gross Margin | 67.2% |
| Operating Margin | 7.9% |
| Report Period | Q3 2025 |
OptimizeRx Corp Annual Revenue by Year
OptimizeRx Corp annual revenue history includes year-by-year totals (for example, 2024 revenue was $92.1M).
| Year | Annual Revenue |
|---|---|
| 2024 | $92.1M |
| 2023 | $71.5M |
| 2022 | $62.5M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28.4M | $19.7M | $18.8M | $21.3M | $32.3M | $21.9M | $29.2M | $26.1M |
| YoY Growth | 44.3% | 51.4% | 36.1% | 30.5% | 13.9% | 11.4% | 55.2% | 22.3% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $183.4M | $176.4M | $172.9M | $165.2M | $171.2M | $167.8M | $169.3M | $170.3M |
| Liabilities | $56.8M | $53.8M | $51.9M | $50.7M | $54.2M | $51.5M | $50.0M | $48.1M |
| Equity | $126.6M | $122.5M | $121.0M | $114.5M | $117.0M | $116.3M | $119.3M | $122.3M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-6.3M | $2.1M | $782000 | $1.8M | $198000 | $3.9M | $4.6M | $3.2M |